Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

A plant-based multicomponent vaccine protects mice from enteric diseases

Abstract

Cholera toxin (CT) B and A2 subunit complementary DNAs (cDNAs) were fused to a rotavirus enterotoxin and enterotoxigenic Escherichia coli fimbrial antigen genes and transferred into potato. Immunoblot and enzyme-linked immunosorbent assay (ELISA) results indicated that the fusion antigens were synthesized in transformed tuber tissues and assembled into cholera holotoxin-like structures that retained enterocyte-binding affinity. Orally immunized mice generated detectable levels of serum and intestinal antibodies against the pathogen antigens. Elevated levels of interleukin 2 (IL2) and interferon γ (INFγ) detected in immunogen-challenged spleen cells from the immunized mice indicated the presence of a strong Th1 immune response to the three plant-synthesized antigens. This result was supported by flow cytometry analysis of immunized mouse spleen cells that showed a significant increase in CD4+ lymphocyte numbers. Diarrhea symptoms were reduced in severity and duration in passively immunized mouse neonates following rotavirus challenge. The results suggest that food plants can function as vaccines for simultaneous protection against infectious virus and bacterial diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Expression of cholera toxin fusion proteins in transgenic potato.
Figure 2: Measurement of anti-CTB, NSP4, and CFA/I antibody titers in mice after oral immunization with transgenic potato tuber tissues.
Figure 3: The adjuvant and carrier functions of CTB in CTB-NSP4 fusion protein.
Figure 4: Measurement of cytokine levels in spleen cells from mice immunized with potato tissues containing CTB, NSP4, and CFA/I proteins.
Figure 5: Detection of CD4+ memory cells in spleen cells from mice immunized with transgenic potato tissues.
Figure 6: Protection against rotavirus infection in passively immunized mouse pups.

Similar content being viewed by others

References

  1. Conner M.E. et al. Development of a mucosal rotaviurs vaccine. In Mucosal vaccines. (eds Kiyono, H., Ogra, P.L. & McGhee, J.R.) 325–326 (Academic Press, San Diego, CA; 1996).

    Chapter  Google Scholar 

  2. Mason, H.S., Lam, D.M. & Arntzen, C.J. Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl. Acad. Sci. USA 89, 11745–11749 (1992).

    Article  CAS  Google Scholar 

  3. Mason, H.S. et al. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its immunogenicity in mice. Proc. Natl. Acad. Sci. USA 93, 5335–5340 (1996).

    Article  CAS  Google Scholar 

  4. Arakawa, T., Chong, D.K., Merritt, J.L. & Langridge, W.H. Expression of cholera toxin B subunit ologomers in transgenic potato plants. Transgenic Res. 6, 403–413 (1997).

    Article  CAS  Google Scholar 

  5. Modelska, A. et al. Immunization against rabies with plant-derived antigen. Proc. Natl. Acad. Sci.USA 95, 2481–2485 (1998).

    Article  CAS  Google Scholar 

  6. Thanavala, Y., Yang, Y.F., Lyons, P., Mason, H.S. & Arntzen, C.J. Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA 92, 3358–3361 (1995).

    Article  CAS  Google Scholar 

  7. Haq, T.A., Mason, H.S., Clements, J.D. & Arntzen, C.J. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268, 714–716 (1995).

    Article  CAS  Google Scholar 

  8. Arakawa, T., Chong, D.K. & Langridge, W.H. Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat. Biotechnol. 16, 292–297 (1998).

    Article  CAS  Google Scholar 

  9. Czerkinsky, C., Russell, M.W., Lycke, N., Lindblad, M. & Holmgren, J. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect. Immun. 57, 1072–1077 (1989).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Holmgren, J., Lycke, N. & Czerkinsky, C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 11, 1179–1184 (1993).

    Article  CAS  Google Scholar 

  11. Bloom, P.D. & Boedeker, E.C. Mucosal immune responses to intestinal bacterial pathogens. Semin. Gastrointest. Dis. 7, 151–166 (1996).

    CAS  PubMed  Google Scholar 

  12. Cox, D.S. & Taubman, M.A. Oral induction of the secretory antibody response by soluble and particulate antigens. Int. Arch. Allergy Appl. Immunol. 75, 126 (1984).

    Article  CAS  Google Scholar 

  13. Mackenzie, S.J. & Halsey, J.F. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J. Immunol. 133, 1818–1824 (1984).

    Google Scholar 

  14. Lycke, N. & Holmgren, J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59, 301–308 (1986).

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Jackson, R.J. et al. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect. Immun. 61, 4272–4279 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Sun, J.B., Holmgren, J. & Czerkinsky, C. Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 91, 10795–10799 (1994).

    Article  CAS  Google Scholar 

  17. Marinaro, M. et al. Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin. J. Immunol. 162, 114–121 (1999).

    CAS  PubMed  Google Scholar 

  18. Williams, N.A., Hirst, T.R. & Nashar, T.O. Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic. Immunol.Today 20, 95–101 (1999).

    Article  CAS  Google Scholar 

  19. Xu-Amano, J. et al. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine 12, 903–911 (1994).

    Article  CAS  Google Scholar 

  20. Arakawa, T. et al. A plant-based cholera toxin B subunit–insulin fusion protein protects against the development of autoimmune diabetes. Nat. Biotechnol. 16, 934–938 (1998).

    Article  CAS  Google Scholar 

  21. Pascual, D.W. et al. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect. Immun. 67, 6249–6256 (1999).

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Ball, J.M., Tian, P., Zeng, C.Q.Y., Morris, A.P. & Estes, M.K. Age-dependent diarrhea induced by a rotavirus nonstructural glycoprotein. Science 272, 101–104 (1996).

    Article  CAS  Google Scholar 

  23. Svennerholm, A.M. et al. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit–whole cell vaccine. J. Infect. Dis. 149, 884–893 (1984).

    Article  CAS  Google Scholar 

  24. Horie, Y. et al. Diarrhea induction by rotavirus NSP4 in the homologous mouse model system. Virology 262, 398–407 (1999).

    Article  CAS  Google Scholar 

  25. Hajishengallis, G., Hollingshead, A.K., Koga, T. & Russell, M.W. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J. Immunol. 154, 4322–4332 (1995).

    CAS  PubMed  Google Scholar 

  26. Dertzbaugh, M.T., Peterson, D.L. & Macrina, F.L. Cholera toxin B–subunit gene fusion: structural and functional analysis of the chimeric protein. Infect. Immun. 58, 70–79 (1990).

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Angel, J., Tang, B., Feng, N., Greenberg, H.B. & Bass, D. Studies of the role for NSP4 in the pathogenesis of homologous murine rotavirus diarrhea. J. Infect. Dis. 177, 455–458 (1998).

    Article  CAS  Google Scholar 

  28. Ishida, S.I., Feng, N., Gibert, J.M., Tang, B. & Greenberg, H.B. Immune responses to individual rotavirus proteins following heterologous and homologous rotavirus infection in mice. J. Infect. Dis. 175, 1317–1323 (1997).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Dr. John Mekalanos (Harvard University School of Medicine) for the gift of the CTX gene, Dr. Mary Estes and Dr. Carl Zeng (Baylor School of Medicine) for providing rotavirus antiserum specific for the NSP4 22–amino acid epitope and rotavirus SA-11 for rotavirus challenge experiments, and for many helpful discussions. Further, we would like to thank Dr. Myron Levine (Center for Vaccine Development, University of Maryland School of Medicine) for providing us with the E. coli CFA/I gene and the CFA/I fimbrial protein. This work was supported in part by a subcontract to W.H.R.L. by the US Army and the National Medical Technology Testbed Inc. and by an intramural grant awarded to W.H.R.L. by Loma Linda University. The views, opinions, and/or findings contained in this report are strictly those of the authors and should not be construed as a position policy, decision, or endorsement of the federal government or of the National Medical Technology Testbed, Inc.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William H.R. Langridge.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, J., Langridge, W. A plant-based multicomponent vaccine protects mice from enteric diseases. Nat Biotechnol 19, 548–552 (2001). https://doi.org/10.1038/89297

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/89297

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing